참고문헌
- Tiede DJ, Nishimura RA, Gastineau DA, et al. Modern management of prosthetic valve anticoagulation. Mayo Clin Proc 1998;73:665-80 https://doi.org/10.4065/73.7.665
- Jack Hirsh. Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001; 119:8S-21S https://doi.org/10.1378/chest.119.1_suppl.8S
- Gage BF, Fihn SD, White RH. Management and dosing of warfarin therapy. Am J Med 2000;109:481-8 https://doi.org/10.1016/S0002-9343(00)00545-3
- Rose JP, Rihn TL, Long SF. Warfarin sensitivity after mechanical heart valve replacement. Pharmacotherapy 1998;18: 856-9
- Cannegieter SC, Rosendaal FR, Wintzen AR, et al. The optimal intensity of oral anticoagulant therapy in patients with mechanical heart valve prosthese: the Leiden artificial valve and anticoagulation study. N Engl J Med 1995;333:11-7 https://doi.org/10.1056/NEJM199507063330103
- Ansell J, Hirsh J, Dalen J, Bussey H, Anderson D, Poller L, Jacobson A, Deykin D. Managing oral anticoagulant therapy. Chest 2001;119:22S-38S https://doi.org/10.1378/chest.119.1_suppl.22S
- Chong Whan Kim,Young Tae Kim. Anticoagulation management after mitral valve replacement with St. Jude medical prosthesis. Korean J Thorac Cardiovasc Surg 1998;31:1172- 82
- Davis FB, Estruch MT, Samson-Cervera EB, et al. Management of anticoagulation in outpatients: Experience with an anticoagulation service in a municipal hospital setting. Arch Intern Med 1977;137:197-202 https://doi.org/10.1001/archinte.137.2.197
- Lee BK. The current state and future plans of anticoagulation service (ACS). Proceedings of the 7th Midyear Clinical Meeting of The Korean Society of Health-system Pharmacists 2001
- Jeong YM, Lee BK, Ahn H. Quality assurance program for anticoagulation service. Proceedings of the 3rd Quality Assurance Conference, Seoul National University Hospital 1997
- Kim CW, Kim YT. Anticoagulation in patients with St. jude medical prosthesis. Korean J Thorac Cardiovasc Surg 1998;31:684-91
- Brigden ML, Kay CLA, Graydon C, McLeod B. Audit of the frequency and clinical response to excessive oral anticoagulation in an out-patient population. Am J Hematol 1998;59:22-7 https://doi.org/10.1002/(SICI)1096-8652(199809)59:1<22::AID-AJH5>3.0.CO;2-1
- Lousberg TR, Witt DM, Beall DG, et al. Evaluation of excessive anticoagulation in a group model health maintenance organization. Arch Intern Med 1998;158:528-34 https://doi.org/10.1001/archinte.158.5.528
- Fihn SD, McDonell M, Martin D, Henikoffs, Vermes D, Kent D, White RH. Risk factors for complications of chronic anticoagulation: A multicenter study. Ann Intern Med 1993;118:511-20 https://doi.org/10.7326/0003-4819-118-7-199304010-00005
- Lee HJ, Hahn HJ, Park KH, Lee BK, Cho NC, Shin WG. The degree of patient's understanding and teaching & counseling for warfarin therapy. J Korean Health-System Phrm 1996;13:341-6
- Kumar S, Haigh JR, Rhodes LE, et al. Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy. Thromb Haemeost 1989;62:729-32
- Wong W, Wilson NJ, Wittkowsky AK. Influence of warfarin regimen type on clinical and monitoring outcomes in stable patients in an anticoagulation management services. Pharmacotherapy 1999;19:1385-91 https://doi.org/10.1592/phco.19.18.1385.30894
- Arnsten JH, Gelfand JM, Singer DE. Determinants of compliance with anticoagulation: a case-control study. Am J Med 1997;103:11-7 https://doi.org/10.1016/S0002-9343(97)90048-6
- Kerin NZ, Blevins RD, Goldman L, Faitel K, Rubenfire M. The incidence, magnitude, and time course of the amiodarone-warfarin interaction. Arch Intern Med 1988;148: 1779-81 https://doi.org/10.1001/archinte.148.8.1779
- Thomas YK Chan. Adverse interactions between warfarin and nonsteroidal antiinflammatory drugs: Mechanisms, clinical significance, and avoidance. Ann Pharmacother 1995;29: 1274-83 https://doi.org/10.1177/106002809502901214
- Cropp JS, Bussey HI. A review of enzyme induction of warfarin metabolism with recommendations for patient management. Pharmacotherapy 1997;17:917-28
- Heck AM, Dewitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm 2000;57:1221-7
- Janetzky K, Morreale AP. Probable interaction between warfarin and ginseng. Am J Heath-syst Pharm 1997;54:692-3
- Taylor JR, Wilt VM. Probable antagonism of warfarin by green tea. Ann Pharmacother 1999;33:426-8 https://doi.org/10.1345/aph.18238
- Booth SL, A. Centurelli MA. Vitamine K: A practical guide to the dietary management of patients on warfarin. Nutrition Reviews 1999;57:288-96 https://doi.org/10.1111/j.1753-4887.1999.tb01815.x
- Goodnight SH. Physiology of coagulation and the role of vitamin K. Managing oral anticoagulation therapy: Clinical and operational guidelines. Gaithersburg, Maryland; An Aspen Publication, 1997:1B-1:1-1B-1:9
- Seo JA, Jeong YM, Chung SY, Kim YJ, Lee BK, Cho NC, Ahn H. Management of warfarin in patients with prosthetic heart valves before dental procedure. The 19th Annual Convention of the Korean Society of Hospital Pharmacists 1999:266-7
- Souto JC, Olover A, Zuazu-Jausoro I, Vives A, Foncuberta J. Oral surgery in anticoagulated patients without reducing the dose of oral anticoagulant: A prospective randomized study. J Oral Maxillofoc Surg 1996;54:27-32 https://doi.org/10.1016/S0278-2391(96)90297-9
- Demirkan K, Stephens MA, Newman KP, Self TH. Response to warfarin and other oral anticoagulants: Effects of disease states. South Med J 2000;93:448-54 https://doi.org/10.1097/00007611-200093050-00001